An **Autoimmune Encephalitis Panel** is a specialized diagnostic test package used to identify autoantibodies attacking brain tissue, leading to acute central nervous system inflammation. This comprehensive panel screens serum or cerebrospinal fluid (CSF) for crucial neural antibodies, including NMDA receptor, LGI1, CASPR2, and GABA-B receptor antibodies.
Autoimmune encephalitis can cause rapid-onset cognitive decline, seizures, psychiatric symptoms, and movement disorders. By detecting specific target antibodies, this test helps neurologists distinguish autoimmune causes from infectious encephalopathies. Early, accurate identification via this panel allows clinicians to promptly initiate targeted immunotherapy, mitigating neurological damage and improving patient outcomes.

**Ascitic Fluid Analysis by Conventional Method** is a fundamental diagnostic evaluation used to determine the underlying cause of abnormal fluid accumulation within the peritoneal cavity (ascites). The conventional procedure involves manual microscopic, chemical, and microbiological examinations, including cell counts, differential analysis, total protein, albumin, and Gram staining.
By evaluating parameters such as the Serum-Ascites Albumin Gradient (SAAG), this traditional methodology effectively differentiates transudative causes (like cirrhosis or heart failure) from exudative causes (such as peritonitis or malignancy). It serves as a reliable, cost-effective cornerstone for clinicians to rapidly guide targeted therapeutic interventions and manage liver disease or abdominal pathologies.

An **Anti-dsDNA Antibody (IFA) Serum** test utilizes Indirect Immunofluorescence Assay (IFA) technology to detect autoantibodies targeting double-stranded DNA. This specialized method often employs *Crithidia luciliae* as a substrate, providing a highly specific substrate (the kinetoplast) to definitively confirm a **Systemic Lupus Erythematosus (SLE)** diagnosis.

By visualizing the fluorescent staining patterns under a microscope, clinicians can accurately differentiate lupus from other autoimmune conditions. Because positive IFA results correlate strongly with active **lupus nephritis**, this serum test serves as a critical biomarker for monitoring disease severity, predicting renal flares, and guiding clinical immunosuppressive therapies.

An **Anti-DNase B (Anti-Deoxyribonuclease B) Serum test** measures antibodies produced by the body in response to a group A *Streptococcus* bacterial infection. While a sore throat is the most common presentation, this specific test is exceptionally valuable for detecting recent **streptococcal skin infections (impetigo)**, where other tests like ASOT can sometimes fail.

Evaluating Anti-DNase B levels helps doctors confirm past strep exposure when investigating delayed, serious complications. These include **acute post-streptococcal glomerulonephritis** (a kidney inflammatory disorder) and **rheumatic fever**, ensuring patients receive the correct, targeted long-term care.

An **Anemia Profile C** is an advanced diagnostic panel designed to comprehensively evaluate complex or chronic cases of anemia. While basic panels focus purely on standard blood counts, Profile C dives deeper into underlying physiological causes, making it a critical tool for detailed clinical investigation.
The profile typically evaluates:
* **Complete Blood Count (CBC):** Assesses hemoglobin levels, hematocrit, and red blood cell indices (MCV, MCH, MCHC).
* **Comprehensive Iron Status:** Measures serum iron, Ferritin, and Total Iron-Binding Capacity (TIBC).
* **Vitamin Markers:** Quantifies Vitamin B12 and Folate levels to identify megaloblastic anemia.
* **Chronic Disease Markers:** Often includes Reticulocyte count or inflammatory indicators to rule out bone marrow suppression or anemia of chronic disease.
This multi-parametric approach allows clinicians to differentiate between simple nutritional deficiencies and more intricate systemic disorders.

An **Anemia Profile M** is a comprehensive diagnostic blood panel designed to evaluate the underlying causes of low hemoglobin and poor red blood cell (RBC) health. It goes beyond a standard blood count to pinpoint specific nutritional deficiencies and production issues.
The profile typically evaluates:
* **Complete Blood Count (CBC) with RBC Indices:** Assesses cell size (MCV) and hemoglobin concentration (MCH, MCHC).
* **Iron Studies:** Measures serum iron, Total Iron-Binding Capacity (TIBC), and ferritin to map out body iron stores.
* **Vitamin B12 & Folate Levels:** Screen for macrocytic or megaloblastic anemias.
It is crucial for identifying iron deficiency, chronic inflammation, or vitamin malabsorption.

An **Anemia Profile - B** is an advanced diagnostic panel designed to investigate complex or persistent cases of anemia that go beyond basic iron deficiency. This profile evaluates critical macrocytic and underlying physiological factors influencing red blood cell production.

It typically includes quantitative measurements of Vitamin B12 and Folic Acid (Folate), which are essential for proper DNA synthesis and erythrocyte maturation. Additionally, it may assess vital iron markers like ferritin, serum iron, and total iron-binding capacity. This comprehensive approach helps clinicians accurately differentiate between megaloblastic anemias, pernicious anemia, and anemias of chronic disease, guiding effective, targeted therapies.

An ANCA by IFA reflex MPO/PR3 serum diagnostic test is a highly specific method used for diagnosing and monitoring ANCA-associated vasculitis (AAV), a rare group of autoimmune diseases that affect small to medium blood vessels.

The test begins with an indirect immunofluorescence assay (IFA) on human serum. This initial step determines the presence of antineutrophil cytoplasmic antibodies (ANCA) and characterizes their staining pattern, typically as either cytoplasmic (c-ANCA) or perinuclear (p-ANCA). If the IFA test yields a positive result, a reflex test is automatically performed. This reflex step uses enzyme-linked immunosorbent assay (ELISA) technology to precisely measure the concentration of antibodies specific for myeloperoxidase (MPO) and proteinase 3 (PR3).

This combined diagnostic approach provides comprehensive data, enabling healthcare providers to accurately identify the specific ANCA-associated vasculitis type, such as granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), or eosinophilic granulomatosis with polyangiitis (EGPA), and initiate appropriate treatment strategies.

An **ANA Screening by IFA Diagnostic Test** (Antinuclear Antibody Screening by Immunofluorescence Assay) is the gold-standard blood test used to detect autoantibodies that mistakenly target a patient's own cellular nuclei. Utilizing a fluorescent microscope, laboratory technicians examine human epithelial cells (HeP-2) mixed with the patient's blood serum to look for specific glowing patterns.

This critical diagnostic screening is the foundational first step in identifying systemic autoimmune conditions, such as Systemic Lupus Erythematosus (SLE), Sjögren's syndrome, and rheumatoid arthritis. A positive result provides crucial initial data, prompting further specific autoantibody testing to establish an accurate medical diagnosis.

The **Aluminium Serum Diagnostic Test** is a specialized blood evaluation used to measure the concentration of aluminium in the body. This test is primarily indicated for patients undergoing long-term kidney dialysis, as they are at a heightened risk of accumulating the metal from dialysis fluids and medications, which can lead to complications like dialysis encephalopathy or metabolic bone disease.

Additionally, it is crucial for monitoring industrial workers exposed to Aluminium dust or fumes. Detecting elevated serum levels allows clinicians to identify toxic exposure early, implement safety interventions, and prevent severe, long-term neurological and skeletal damage.

The **Alpha-Fetoprotein (AFP) Diagnostic Test** is a crucial blood screening tool primarily used to measure the levels of AFP, a protein produced mainly by the fetal liver and yolk sac. In pregnant individuals, elevated or abnormally low maternal serum AFP levels can indicate potential fetal neural tube defects, like spina bifida, or chromosomal abnormalities.

For adults, the AFP test serves as an essential tumor marker. Significantly elevated levels are strongly associated with liver cancer (hepatocellular carcinoma) and certain germ cell tumors of the ovaries or testes, aiding clinicians in cancer diagnosis, staging, and monitoring treatment efficacy.

An Egg Yolk (Anda) Individual Food Allergen test is a specific blood diagnostic tool used to identify allergic sensitivity to the proteins contained within egg yolks. Although egg whites are more commonly associated with allergic reactions, the yolk also contains distinct proteins that can trigger an inappropriate immune response.

The test measures the concentration of specific IgE antibodies in the serum produced against egg yolk proteins. Identifying an egg yolk allergy helps healthcare providers create tailored dietary management plans, helping individuals safely avoid trigger foods and prevent allergic symptoms ranging from mild hives and gastrointestinal discomfort to severe anaphylaxis.